Login / Signup

Treatment pattern trends of medications for type 2 diabetes in British Columbia, Canada.

Greg CarneyJason D KimCait O'SullivanWade ThompsonKen BassettJosh LevinColin R Dormuth
Published in: BMJ open diabetes research & care (2022)
Oral diabetic medication patterns have changed significantly over the last 20 years in BC, primarily in terms of medications used as second-line therapy. Over 40% of patients with available laboratory results initiated T2DM treatment with an A1C value ≤7.0%, with the average A1C value trending lower over the last decade.
Keyphrases
  • type diabetes
  • healthcare
  • emergency department
  • glycemic control
  • stem cells
  • metabolic syndrome
  • insulin resistance
  • adipose tissue
  • skeletal muscle
  • cell therapy